<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz - link info</title>
<link>http://netvouz.com/url/60188d9d4206096512807e5e433422b5?feed=rss</link>
<description>Info about a link</description>
<item><title>Regulatory Submission</title>
<link>http://lotuslabs.com/en/regulatory-submission.aspx</link>
<description>The Regulatory Submission Teams at Lotus Labs are committed to ensuring best-in-class regulatory submissions with sound knowledge of regulatory requirements, international norms &amp;interacting with global regulatory bodies enable us to ensure quality &amp; reliable compliance with regards to study submissions. The regulatory submission activities include Formulation of regulatory strategies, Compilation of the clinical trial application, Submission and follow-up of the application, Response to regulatory agency queries, Procurement of drug import licenses, Procurement of NOC for export of biological samples and many more as required by the sponsor.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Thu, 14 Nov 2013 05:53:49 GMT</pubDate>
</item><item><title>State-of-the-Art Phase I Clinical Trial Facilities</title>
<link>http://lotuslabs.com/en/regulatory-submission.aspx</link>
<description>Lotus Labs has independent Phase I clinical trial facility &amp; the expertise to conduct First-In-Human Studies, Pharmacokinetic studies, Bio-availability &amp; Bio-equivalence studies, Drug Metabolism studies, Dose Proportionality &amp; Multiple dose studies &amp; more.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Wed, 14 Aug 2013 06:05:08 GMT</pubDate>
</item></channel></rss>